Rufinamide-d2(Synonyms: CGP 33101-d2; E 2080-d2; RUF 331-d2)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物,专注于信号通路和疾病研究领域。
Rufinamide-d2 (Synonyms: CGP 33101-d2; E 2080-d2; RUF 331-d2)

Rufinamide-d2 (CGP 33101-d2) 是 Rufinamide 的氘代物。Rufinamide (E 2080; CGP 33101; RUF 331)是新型镇痫化合物,可用于 Lennox-Gastaut 综合症的的研究。

Rufinamide-d2(Synonyms: CGP 33101-d2;  E 2080-d2;  RUF 331-d2)

Rufinamide-d2 Chemical Structure

CAS No. : 1129491-38-8

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Rufinamide-d2 (CGP 33101-d2) is the deuterium labeled Rufinamide. Rufinamide (E 2080) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS).

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

240.21

Formula

C10H6D2F2N4O

CAS 号

1129491-38-8

中文名称

卢非酰胺 d2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Suter MR, Kirschmann G, Laedermann CJ, Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state. Anesthesiology. 2013 Jan;118(1):160-72.

    [3]. White HS, Franklin MR, Kupferberg HJ, The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models. Epilepsia. 2008 Jul;49(7):1213-20.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务